Procter & Gamble Hygiene and Health Care Ltd Q4 FY26 results (latest), Jan–Mar 2026 →Revenue ₹941 Cr −5.1% YoYSee revenue, profit and what management said. You are viewing Q4 FY25.
P&

Procter & Gamble Hygiene and Health Care Ltd

Q4 FY25Personal Products

Procter & Gamble Hygiene and Health Care Q4 FY25 earnings call: Revenue & Margins

Q4 FY25 earnings call: what management said on revenue, margins and capex.

Revenue
₹992Cr
−1% YoY
−20.5% QoQ
Net profit
₹156Cr
+1.3% YoY
−42% QoQ
Margin
21%
−5 pp YoY
−9 pp QoQ
Price₹8,189
Market cap₹27.5K Cr
P/E34.8

The short version

The company aims to grow ahead of the industry average, focusing on consistent and sustained growth rooted in a deep understanding of evolving consumer needs. The company aims to grow at a rate ahead of the industry average with consistent, sustained growth rooted in a deep understanding of evolving consumer needs and superior propositions.

From Procter & Gamble Hygiene and Health Care Ltd's Q4 FY25 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • The company aims to grow ahead of the industry average, focusing on consistent and sustained growth rooted in a deep understanding of evolving consumer needs.
  • Growth strategy centers on driving category expansion by uncovering and serving new "jobs to be done" for consumers.
  • Significant opportunity exists to grow consumption and innovation within existing categories, particularly by increasing household penetration among unserved and underserved consumers.
  • Innovation pipeline is robust, with recent quarters showing strong new product introductions designed to attract new users and address new consumer needs.
  • Feminine care category has substantial runway as penetration is under 50%, with market leadership maintained and growth driven by product upgrades and education.
  • Healthcare category innovations such as Vicks Steam Pods and Zzzquil are seeing positive market response, supporting growth.

2 more points from Procter & Gamble Hygiene and Health Care Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Procter & Gamble Hygiene and Health Care Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

The following points can be inferred regarding investment focus: - Continued investment in innovation, with one of the strongest innovation pipelines seen in recent years. - Ongoing investment in digital transformation and AI-driven analytics to optimize product assortment and retail execution. - Investment in productivity initiatives, delivering cost savings of Rs. 93 crores last year, enabling reinvestment in superiority and growth. - Focus on building and upgrading product portfolios across categories including feminine care and healthcare.

2 more points from Procter & Gamble Hygiene and Health Care Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Personal Products

Ranked on what management guided this quarter

Guidance-ranked
Rev 1Mar 1
2Recode Studios
Rev 1Mar 3
3
Rev 2Mar 3
4
Rev 2Mar 3
5
Rev 3Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Procter & Gamble Hygiene and Health Care Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what Procter & Gamble Hygiene and Health Care Ltd said on order book & pipeline — free account, 30 seconds.

Procter & Gamble Hygiene and Health Care Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Procter & Gamble Hygiene and Health Care Ltd Q4 FY25 results — key figures

Procter & Gamble Hygiene and Health Care Ltd Q4 FY25 reported results vs Q4 FY24, ₹ crore
₹ CrQ4 FY25Q4 FY24YoYQ3 FY25QoQ
Revenue9921,002-1%1,248-20.5%
Operating profit (EBITDA)210257-18.3%371-43.4%
Operating margin21%26%-5 pp30%-9 pp
Profit before tax213234-9%364-41.5%
Net profit (PAT)156154+1.3%269-42%
EPS (₹)48.0947.56+1.1%82.74-41.9%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹1.1K Cr, net profit ₹196 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Personal Products this season

  • Cupid (Q4 FY25)

    125 crores by FY26, indicating +150% growth (Page 29, 18). Key concall takeaways from Cupid Ltd's Q4 FY25 earnings call — and how it ranks against sector peers.

  • Gillette India (Q4 FY25)

    Gillette India delivered a 12% sales growth and 40% profit growth in the past year, reflecting strong execution of their Integrated Growth Strategy. Key…

  • Emami (Q4 FY25)

    Dividend payouts were highlighted, with a total dividend of 1000% or Rs. Key concall takeaways from Emami Ltd's Q4 FY25 earnings call — and how it ranks…

  • Colgate-Palmoliv (Q4 FY25)

    The premium 30% urban segment remains resilient and continues to drive growth. Key concall takeaways from Colgate-Palmolive (India) Ltd's Q4 FY25 earnings call…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Procter & Gamble Hygiene and Health Care Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Procter & Gamble Hygiene and Health Care Ltd Q4 FY25 results?

The company aims to grow ahead of the industry average, focusing on consistent and sustained growth rooted in a deep understanding of evolving consumer needs. The company aims to grow at a rate ahead of the industry average with consistent, sustained growth rooted in a deep understanding of evolving consumer needs and superior propositions.

What is Procter & Gamble Hygiene and Health Care Ltd share price analysis?

Procter & Gamble Hygiene and Health Care Ltd currently shows a neutral. The stock trades at a P/E of 34.8 with a market cap of ₹27,541 Cr. Investors should review the full earnings analysis for detailed insights.

Keep Procter & Gamble Hygiene and Health Care Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.